Literature DB >> 31336113

Social perceptual function in parkinson's disease: A meta-analysis.

Sarah P Coundouris1, Alexandra G Adams2, Sarah A Grainger2, Julie D Henry2.   

Abstract

Social perceptual impairment is a common presenting feature of Parkinson's disease (PD) that has the potential to contribute considerably to disease burden. The current study reports a meta-analytic integration of 79 studies which shows that, relative to controls, PD is associated with a moderate emotion recognition deficit (g = -0.57, K = 73), and that this deficit is robust and almost identical across facial and prosodic modalities. However, the magnitude of this impairment does appear to vary as a function of task and emotion type, with deficits generally greatest for identification tasks (g = -0.65, K = 54), and for negative relative to other basic emotions. With respect to clinical variables, dopaminergic medication, deep brain stimulation, and a predominant left side onset of motor symptoms are each associated with greater social perceptual difficulties. However, the magnitude of social perceptual impairment seen for the four atypical parkinsonian conditions is broadly comparable to that associated with PD. The theoretical and practical implications of these findings are discussed.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Deep brain stimulation; Dopaminergic medication; Emotion recognition; Parkinson plus syndromes; Parkinson’s disease; Side of motor symptom onset; Social perception; Stimulus modality; Task type

Mesh:

Year:  2019        PMID: 31336113     DOI: 10.1016/j.neubiorev.2019.07.011

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  8 in total

Review 1.  Effects of Subthalamic Nucleus Deep Brain Stimulation on Facial Emotion Recognition in Parkinson's Disease: A Critical Literature Review.

Authors:  S Kalampokini; E Lyros; P Lochner; K Fassbender; M M Unger
Journal:  Behav Neurol       Date:  2020-07-17       Impact factor: 3.342

2.  Evidence for a vocal signature in the rat and its reinforcing effects: a key role for the subthalamic nucleus.

Authors:  Cassandre Vielle; Christian Montanari; Yann Pelloux; Christelle Baunez
Journal:  Proc Biol Sci       Date:  2021-12-15       Impact factor: 5.349

3.  Deficits in Emotion Recognition and Theory of Mind in Parkinson's Disease Patients With and Without Cognitive Impairments.

Authors:  Alessandra Dodich; Giulia Funghi; Claudia Meli; Maria Pennacchio; Chiara Longo; Maria Chiara Malaguti; Raffaella Di Giacopo; Francesca Zappini; Luca Turella; Costanza Papagno
Journal:  Front Psychol       Date:  2022-05-13

4.  The effect of directional social cues on saccadic eye movements in Parkinson's disease.

Authors:  Koray Koçoğlu; Gülden Akdal; Berril Dönmez Çolakoğlu; Raif Çakmur; Jagdish C Sharma; Gemma Ezard; Frouke Hermens; Timothy L Hodgson
Journal:  Exp Brain Res       Date:  2021-04-29       Impact factor: 1.972

5.  Social Cognition in Patients with Early-Onset Parkinson's Disease.

Authors:  Ana Natalia Seubert-Ravelo; Ma Guillermina Yáñez-Téllez; María Lizbeth Lazo-Barriga; Alejandra Calderón Vallejo; Carlos Eduardo Martínez-Cortés; Adela Hernández-Galván
Journal:  Parkinsons Dis       Date:  2021-01-07

6.  Motor symptom asymmetry predicts non-motor outcome and quality of life following STN DBS in Parkinson's disease.

Authors:  Philippe Voruz; Jordan Pierce; Kévin Ahrweiller; Claire Haegelen; Paul Sauleau; Sophie Drapier; Dominique Drapier; Marc Vérin; Julie Péron
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.996

7.  Laterality of motor symptom onset and facial expressivity in Parkinson disease using face digitization.

Authors:  Adrianna M Ratajska; Anne N Nisenzon; Francesca V Lopez; Alexandra L Clark; Didem Gokcay; Michael S Okun; Dawn Bowers
Journal:  Laterality       Date:  2021-07-05

Review 8.  Approach to Cognitive Impairment in Parkinson's Disease.

Authors:  Qiang Zhang; Georgina M Aldridge; Nandakumar S Narayanan; Steven W Anderson; Ergun Y Uc
Journal:  Neurotherapeutics       Date:  2020-11-17       Impact factor: 6.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.